Physiological aspects of high-altitude pulmonary edema

Journal of Applied Physiology

Volumn 98, Issue 3, 2005, Pages 1101-1110

  Bärtsch, Peter ^a   Mairbäurl, Heimo ^a   Maggiorini, Marco ^b   Swenson, Erik R ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Alveolar fluid clearance; Hypoxic pulmonary vasoconstriction; Inflammation; Nitric oxide; Pathophysiology; Pulmonary artery pressure; Review

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE; PROTEIN;

ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; ERYTHROCYTE; EXPIRED AIR; HEART CATHETERIZATION; HEART LEFT ATRIUM PRESSURE; HIGH ALTITUDE PULMONARY EDEMA; HUMAN; HYDROSTATIC PRESSURE; HYPOXIA; INFLAMMATION; LUNG ALVEOLUS; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG CAPILLARY PRESSURE; LUNG EDEMA; LUNG LAVAGE; LUNG VASOCONSTRICTION; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STRESS; SWINE;

ALTITUDE; ALTITUDE SICKNESS; ANIMALS; HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY CIRCULATION; PULMONARY EDEMA;

EID: 14144256291     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01167.2004     Document Type: Review

References (123)

1. Adamson RH, Liu B, Fry GN, Rubin L, and Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol Heart Circ Physiol 274: H1885-H1894, 1998.
2. Adding LC, Agvald P, Artlich A, Persson MG, and Gustafson LE. Beta-adrenoceptor agonist stimulation of pulmonary nitric oxide production in the rabbit. Br J Pharmacol 126: 833-839, 1999.
3. Albert RK, Lakshminarayan S, Hildebrandt J, Kirk W, and Butler J. Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs. J Clin Invest 63: 1015-1018, 1979.
4. Anand IS, Malhotra RM, Chandrashekhar Y, Bali HK, Chauhan SS, Jindal SK, Bhandari RK, and Wahi PL. Adult subacute mountain sickness-a syndrome of congestive heart failure in man at very high altitude. Lancet 335: 561-565, 1990.
5. Anand IS, Prasad BAK, Chugh SS, Rao KRM, Cornfield DN, Milla CE, Singh N, Singh S, and Selvamurthy W. Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema. Circulation 98: 2441-2445, 1998.
6. Antezana G, Leguia G, Morales Guzman A, Coudert J, and Spielvogel H. Hemodynamic study of high altitude pulmonary edema (12,200 ft). In: High Altitude Physiology and Medicine, edited by Brendel W and Zink RA. New York: Springer Verlag, p. 232-241, 1982.
7. Arias-Stella J and Kruger H. Pathology of high altitude pulmonary edema. Arch Pathol 76: 147-157, 1963.
8. Bachofen H, Schürch S, and Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: barrier lesions. Am Rev Respir Dis 147: 997-1004, 1993.
9. Bärtsch P. High altitude pulmonary edema. Med Sci Sports Exerc 31: S23-S27, 1999.
10. Bärtsch P, Haeberli A, Franciolli M, Kruithof EKO, and Straub PW. Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema. J Appl Physiol 66: 2136-2144, 1989.
11. Bärtsch P, Haeberli A, Nanzer A, Lämmle B, Vock P, Oelz O, and Straub PW. High altitude pulmonary edema: blood coagulation. In: Hypoxia and Molecular Medicine, edited by Sutton JR, Houston CS, and Coates G. Burlington, VT: Queen City Printers, 1993, p. 252-258.
12. Bärtsch P, Lämmle B, Huber I, Haeberli A, Vock P, Oelz O, and Straub PW. Contact phase of blood coagulation is not activated in edema of high altitude. J Appl Physiol 67: 1336-1340, 1989.
13. Bärtsch P, Maggiorini M, Mairbäurl H, Vock P, and Swenson E. Pulmonary extravascular fluid accumulation in climbers (Letter). Lancet 360: 571, 2002.
14. Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, and Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 325: 1284-1289, 1991.
15. Bärtsch P, Shaw S, Franciolli M, Gnädinger MP, and Weidmann P. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 65: 1929-1937, 1988.
16. Bärtsch P, Swenson ER, and Maggiorini M. Update: high altitude pulmonary edema. In: Hypoxia: From Genes to the Bedside, edited by Roach RC. New York: Kluwer Academic/Plenum, 2001, p. 89-106.
17. Bärtsch P, Vock P, and Franciolli M. High altitude pulmonary edema after successful treatment of acute mountain sickness with dexamethasone. Wilderness Med 1: 162-164, 1990.
18. Bärtsch P, Waber U, Haeberli A, Maggiorini M, Kriemler S, Oelz O, and Straub WP. Enhanced fibrin formation in high-altitude pulmonary edema. J Appl Physiol 63: 752-757, 1987.
19. Beall CM, Laskowski D, Strohl KP, Soria R, Villena M, Vargas E, Alarcon AM, Gonzales C, and Erzurum SC. Pulmonary nitric oxide in mountain dwellers. Nature 414: 411-412, 2001.
20. 19a. Berger M, Hesse C, Dehnert C, Siedler H, Kleinbongard P, Gharini P, Bardenheuer H, Kelm M, Bärtsch P, and Haefeli W. Hypoxia impairs endothelial function in individuals susceptible to high-altitude pulmonary oedema (HAPE): the missing link in the pathogenesis of HAPE (Abstract)? High Alt Med Biol. In press.
21. Busch T, Bärtsch P, Pappert D, Grünig E, Elser H, Falke KJ, and Swenson ER. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high altitude pulmonary edema. Am J Respir Crit Care Med 163: 368-373, 2001.
22. Caillaud C, Serre-Cousiné O, Anselme F, Capdevilla X, and Préfaut C. Computerized tomography and pulmonary diffusing capacity in highly trained athletes after performing a triathlon. J Appl Physiol 79: 1226-1232, 1995.
23. Canning BJ. Neurology of allergic inflammation and rhinitis. Curr Allergy Asthma Rep 2: 210-215, 2002.
24. Carpenter TD, Reeves JT, and Durmowicz AG. Viral respiratory infection increases susceptibility of young rats to hypoxia-induced pulmonary edema. J Appl Physiol 84: 1048-1054, 1998.
25. Chapleau MW, Wilson LB, Gregory TJ, and Levitzky MG. Chemoreceptor stimulation interferes with regional hypoxic pulmonary vasoconstriction. Respir Physiol 71: 185-200, 1988.
26. Davis KL, Mehlhorn U, Laine GA, and Allen SJ. Myocardial edema, left ventricular function, and pulmonary hypertension. J Appl Physiol 78: 132-137, 1995.
27. Dehnert C, Weymann J, Montgomery HE, Woods D, Maggiorini M, Scherrer U, Gibbs JSR, and Bärtsch P. No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 34: 1928-1933, 2002.
28. DeRijk RH, Schaaf M, and de Kloet ER. Glucocorticoid receptor variants: clinical implications. J Steroid Biochem Mol Biol 81: 103-122, 2002.
29. Droma Y, Hanaoka M, Ota M, Katsuyama Y, Koizumi T, Fujimoto K, Kobayashi T, and Kubo K. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 106: 826-830, 2002.
30. Duplain H, Sartori C, Lepori M, Egli M, Allemann Y, Nicod P, and Scherrer U. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 162: 221-224, 2000.
31. Duplain H, Vollenweider L, Delabays A, Nicod P, Bärtsch P, and Scherrer U. Augmented sympathetic activation during short-term hypoxia and high-altitude exposure in subjects susceptible to high-altitude pulmonary edema. Circulation 99: 1713-1718, 1999.
32. Durmowicz AG, Nooordeweir E, Nicholas R, and Reeves JT. Inflammatory processes may predispose children to develop high altitude pulmonary edema. J Pediatr 130: 838-840, 1997.
33. Dvorak AM and Feng D. The vesiculo-vacuolar organelle (VVO): a new endothelial cell permeability organelle. J Histochem Cytochem 49: 419-431, 2001.
34. Egli M, Duplain H, Lepori M, Cook S, Nicod P, Hummler E, Sartori C, and Scherrer U. Defective respiratory amiloride sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice. J Physiol 560: 857-865, 2004.
35. Eldridge MW, Podolsky A, Richardson RS, Johnson DH, Knight DR, Johnson EC, Hopkins SR, Michimata H, Grassi B, Feiner J, Kurdak SS, Bickler PE, Wagner PD, and Severinghaus JW. Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. J Appl Physiol 81: 911-921, 1996.
36. Gabry AL, Ledoux X, Mozziconacci M, and Martin C. High-altitude pulmonary edema at moderate altitude (<2,400 m; 7,870 feet). Chest 123: 49-53, 2003.
37. Ghofrani HA, Reichenberger F, Kohstall MG, Mrosek EH, Seeger T, Olschewski H, Seeger W, and Grimminger F. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest Base Camp. Ann Intern Med 141: 169-177, 2004.
38. Groves BM, Droma T, Sutton JR, McCullough RG, McCullough RE, Zhuang J, Rapmund G, Sun S, Janes G, and Moore LG. Minimal hypoxic pulmonary hypertension in normal Tibetans at 3,658 m. J Appl Physiol 74: 312-318, 1993.
39. Grünig E, Mereles D, Hildebrandt W, Swenson ER, Kübler W, Kuecherer H, and Bärtsch P. Stress Doppier echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol 35: 980-987, 2000.
40. Hackett PH, Creagh CE, Grover KF, Honigman B, Houston CS, Reeves JT, Sophocles AM, and van Hardenbroek M. High altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 302: 1070-1073, 1980.
41. Hackett PH, Rennie D, and Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet II: 1149-1154, 1976.
42. Hackett PH and Roach RC. High-altitude illness. N Engl J Med 345: 107-114, 2001.
43. Hackett PH, Roach RC, Schoene RB, Harrison GL, and Mills WJ. Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol 64: 1268-1272, 1988.
44. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourt FP, Plumier JC, Rebdamen MC, Hsieh CM, Chui DS, Thomas KL, Prorock A, Laubach VE, Moskowitz MA, French BA, Ley K, and Liao JK. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide. synthase. Nat Med 8: 473-479, 2002.
45. Hakim TS and Kelly S. Occlusion pressures vs. micropipette pressures in the pulmonary circulation. J Appl Physiol 67: 1277-1285, 1989.
46. Hanaoka M, Droma Y, Hotta J, Matsuzawa Y, Kobayashi T, Kubo K, and Ota M. Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest 123: 54-58, 2003.
47. Hlastala MP, Lamm WJE, Karp A, Polissar NL, Starr IR, and Glenny RW. Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J Appl Physiol 96: 1589-1599, 2004.
48. Hohenhaus E, Paul A, McCullough RE, Kücherer H, and Bärtsch P. Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J 8: 1825-1833, 1995.
49. Homik LA, Bshouty RB, Light RB, and Younes M. Effect of alveolar hypoxia on pulmonary fluid filtration in in situ dog lungs. J Appl Physiol 65:46-52; 1988.
50. Hopkins SR, Garg J, Bolar DS, Balouch J, and Levin DL. Pulmonary blood flow heterogeneity during hypoxia and high altitude pulmonary edema. Am J Respir Crit Care Med doi:10.1164/rccm.200406-707OC. 2004.
51. Hopkins SR, Schoene RB, Henderson WR, Spragg RG, Martin TR, and West JB. Intense exercise impairs the integrity of the pulmonary blood-gas barrier in elite athletes. Am J Respir Crit Care Med 155: 1090-1094, 1997.
52. Höschele S and Mairbäurl H. Alveolar flooding at high altitude: failure of reabsorption? News Physiol Sci 18: 55-59, 2003.
53. Hotta J, Hanaoka M, Droma Y, Katsuyama M, Ota M, and Kobyashi T. Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest 126: 825-830, 2004.
54. Houston CS. Acute pulmonary edema of high altitude. N Engl J Med 263: 478-480, 1960.
55. Hultgren HN, Grover RF, and Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation 44: 759-770, 1971.
56. Hultgren HN, Honigman B, Theis K, and Nicholas D. High-altitude pulmonary edema at a ski resort. West J Med 164: 222-227, 1996.
57. Hultgren HN, Lopez CE, Lundberg E, and Miller H. Physiologic studies of pulmonary edema at high altitude. Circulation 29: 393-408, 1964.
58. Hultgren NH. High altitude pulmonary edema. In: Lung Water Solute Exchange, edited by Staub NC. New York: Dekker, p. 437-464, 1978.
59. Hyers TM, Fowler AA, and Wicks AB. Focal pulmonary edema after massive pulmonary embolism. Am Rev Respir Dis 123: 232-233, 1981.
60. Hyers TM, Scoggin CH, Will DH, Grover RF, and Reeves JT. Accentuated hypoxemia at high altitude in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 46: 41-46, 1979.
61. Kaminsky DA, Jones K, Schoene RB, and Voelkel NF. Urinary leuktriene E (4) levels in high-altitude pulmonary edema: a possible role for inflammation. Chest 110: 939-945, 1996.
62. Kawashima A, Kubo K, Kobayashi T, and Sekiguchi M. Hemodynamic responses to acute hypoxia, hypobaria, and exercise in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 67: 1982-1989, 1989.
63. Koyama S, Kobayashi T, Kubo K, Fukushima M, Yoshimura K, and Shibamoto TKS. The increased sympathoadrenal activity in patients with high altitude pulmonary edema is centrally mediated. Jpn J Med 27: 10-16, 1988.
64. Kubo K, Hanaoka M, Yamaguchi S, Hayano T, Hayasaka M, Koizumi T, Fujimoto K, Kobayashi T, and Honda T. Cytokines in bronchoalveolar lavage fluid in patients with high altitude pulmonary oedema at moderate altitude in Japan. Thorax 51: 739-742, 1996.
65. Kumar R, Pasha Q, Kann AP, and Gupta V. Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high altitude pulmonary edema. Aviat Space Environ Med 75: 981-983, 2004.
66. Lear GH. Neurogenic pulmonary oedema. Acta Paediatr Scand 79: 1131-1133, 1990.
67. Litch JA and Bishop RA. Reascent following resolution of high altitude pulmonary edema (HAPE) (Case Report). High Alt Med Biol 2: 53-55, 2001.
68. Lizarraga L. Soroche agudo: Edema agudo del pulmón. An Fac Med (San Marco, Lima) 38: 244-274, 1955.
69. Maggiorini M, Brunner-La Rocca HP, Bärtsch P, Fischler MT, Böhm Bloch KE, and Mairbäurl H. Dexamethasone and tadalafil prophylaxis prevents both excessive pulmonary constriction and high altitude pulmonary edema in susceptible subjects (Abstract). Eur Respir J 24: 110s, 2004.
70. Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, and Naeije R. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103: 2078-2083, 2001.
71. Mairbäurl H, Mayer K, Kim KJ, Borok Z, Bärtsch P, and Crandall ED. Hypoxia decreases active Na transport across primary rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 282: L659-L665, 2002.
72. Mairbäurl H, Weymann J, Möhrlein A, Swenson ER, Maggiorini M, Gibbs JSR, and Bärtsch P. Nasal epithelium potential difference at high altitude (4,559 m). Am J Respir Crit Care Med 167: 862-867, 2003.
73. Matsuzawa Y, Fujimoto K, Kobayashi T, Namushi NR, Harada K, Kohno H, Fukushima M, and Kusama S. Blunted hypoxic ventilatory drive in subjects susceptible to high-altitude pulmonary edema. J Appl Physiol 66: 1152-1157, 1989.
74. Matthay MA, Clerici C, and Saumon C. Active fluid clearance from distal airspaces. J Appl Physiol 93: 1533-1541, 2002.
75. Miller WT, Osiason AW, Langlotz CP, and Palevsky HI. Reperfusion edema after thromboendarterectomy: radiographic patterns of disease. J Thorac Imaging 13: 178-183, 1998.
76. Ming Z and Wang DX. Sympathetic innervation of pulmonary circulation ant its role in hypoxic pulmonary vasoconstriction. J Tongji Med Univ 9: 153-159, 1989.
77. Murata T, Hori M, Sakamoto K, Karaki H, and Ozaki H. Dexamethasone blocks hypoxia-induced endothelial dysfunction in organ-cultured pulmonary arteries. Am J Respir Crit Care Med 170: 647-655, 2004.
78. Nayak NC, Roy S, and Narayanan TK. Pathologic features of altitude sickness. Am J Pathol 45: 381-391, 1964.
79. Neal CR and Michel CC. Openings in frog microvascular endothelium induced by high intravascular pressures. J Physiol 492: 39-52, 1996.
80. Oelz O, Ritter M, Jenni R, Maggiorini M, Waber U, Vock P, and Bärtsch P. Nifedipine for high altitude pulmonary oedema. Lancet 2: 1241-1244, 1989.
81. Parker JC and Ivey CL. Isoproterenol attenuates high vascular pressure-induced permeability increases in isolated rat lungs. J Appl Physiol 83: 1962-1967, 1997.
82. Parker JC, Ivey CL, and Tucker JA. Gadolinium prevents high airway pressure-induced permeability increases in isolated rat lungs. J Appl Physiol 84: 1113-1118, 1998.
83. Parker JC and Yoshikawa S. Vascular segmental permeabilities at high peak inflation pressure in isolated rat lungs. Am J Physiol Lung Cell Mol Physiol 283: L1203-1209, 2002.
84. Penaloza D and Sime F. Circulatory dynamics during high altitude pulmonary edema. Am J Cardiol 23: 369-378, 1969.
85. Pham I, Uchida T, Planes C, Ware LB, Kaner R, Matthay MA, and Clerici C. Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 283: L1133-L1142, 2002.
86. Planes C, Escoubet B, Blot-Chabaud M, Friedlander G, Farman N, and Clerici C. Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells. Am J Respir Cell Mol Biol 17: 508-518, 1997.
87. Raj JU and Chen P. Micropuncture measurement of microvascular pressures in isolated lamb lungs during hypoxia. Circ Res 59: 398-404, 1986.
88. Richalet JP, Gratadour P, Robach P, Pham I, Déchaux M, Joncquiert-Latarjet A, Mollard P, Brugniaux J, and Cornolo J. Sildenafil inhibits the altitude-induced hypoxemia and pulmonary hypertension. Am J Resp Crit Care Med doi:10.1164/rccm.200406-804OC: 2004.
89. Ritter M, Jenni R, Maggiorini M, Grimm J, and Oelz O. Abnormal left ventricular diastolic filling patterns in acute hypoxic pulmonary hypertension at high altitude. Am J Noninvas Cardiol 7: 33-38, 1993.
90. Rock P, Patterson GA, Permutt S, and Sylvester JT. Nature and distribution of vascular resistance in hypoxic pig lungs. J Appl Physiol 59: 1891-1901, 1985.
91. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, Nicod P, and Scherrer U. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 346: 1631-1636, 2002.
92. Sartori C, Duplain H, Lepori M, Egli M, Maggiorini M, Nicod P, and Scherrer U. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J 23: 916-920, 2004.
93. Sartori C, Lipp E, Duplain H, Egli M, Hutter D, Allemann Y, Nicod P, and Scherrer U. Prevention of high altitude pulmonary edema by beta-adrenergic stimulation of the alveolar transepithelial sodium transport (Abstract). Am Respir Crit Care Med 161: A415, 2000.
94. Sartori C, Vollenweider L, Löffler BM, Delabays A, Nicod P, Bärtsch P, and Scherrer U. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99: 2665-2668, 1999.
95. Scherrer U, Sartori C, Lepori M, Allemann Y, Duplain H, Trueb L, and Nicod P. High-altitude pulmonary edema: from exaggerated pulmonary hypertension to a defect in transepithelial sodium transport. Adv Exp Med Biol 474: 93-107, 1999.
96. Scherrer U, Vollenweider L, Delabays A, Savcic M, Eichenberger U, Kleger GR, Firkrle A, Ballmer P, Nicod P, and Bärtsch P. Inhaled nitric oxide for high-altitude pulmonary edema. N Engl J Med 334: 624-629, 1996.
97. Schoene RB. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol 5: 125-135, 2004.
98. Schoene RB, Swenson ER, and Hultgren HN. High-altitude pulmonary edema. In: High Altitude-An Exploration of Human Adaptation, edited by Hornbein TF and Schoene R. New York: Dekker, 2001, p. 777-814.
99. Schoene RB, Swenson ER, Pizzo CJ, Hackett PH, Roach RC, Mills WJ, Henderson WR, and Martin TR. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema. J Appl Physiol 64: 2605-2613, 1988.
100. Schütte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, and Seeger W, Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 9: 1858-1867, 1996.
101. Singh I and Roy SB. High altitude pulmonary edema: clinical, hemodynamic, and pathologic studies. In: Biomedicine of High Terrestrial Elevation Problems. Washington, DC: US Army Research and Development Command, 1969, p. 108-120.
102. Steinacker JM, Tobias E, Menold E, Reißnecker S, Hohenhaus E, Liu Y, Lehmann M, Bärtsch P, and Swenson ER. Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary edema. Eur Respir J 11: 643-650, 1998.
103. Stelzner TJ, O'Brien RF, Sato IC, and Weil JV. Hypoxia-induced increases in pulmonary transvascular protein escape in rats; modulation by glucocorticoids. J Clin Invest 82: 1840-1847, 1988.
104. Sui GJ, Liu YH, Cheng XS, Anand IS, Harris E, Harris P, and Heath D. Subacute infantile mountain sickness. J Pathol 155: 161-170, 1988.
105. Swenson ER and Maggiorini M. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 347: 1284, 2002.
106. Swenson EK, Maggiorini M, Mongovin S, Gibbs JSR, Greve I, Mairbäurl H, and Bärtsch P. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA 287: 2228-2235, 2002.
107. Szidon JP, Pietra GG, and Fishman AP. The alveolar-capillary membrane and pulmonary edema. N Engl J Med 286: 1200-1204, 1972.
108. 4 concentrations of lung edema fluid produced by high capillary pressures in rabbit. J Appl Physiol 76: 321-327, 1994.
109. van Heerden PV, Cameron PD, Karanovic A, and Goodman MA. Orthodeoxia-an uncommon presentation following bilateral sympathectomy. Anaesth Intensive Care 31: 581-583, 2003.
110. Visscher MB. The Discussant. Pulmonary edema at high altitude (panel discussion). Med Thorac 19: 326-327, 1962.
111. Viswanathan R, Jain SK, Subramanian S, Subramanian TAV, Dua GL, and Giri J. Pulmonary edema of high altitude II. Clinical, aerohemodynamic, and biochemical studies in a group with history of pulmonary edema of high altitude. Am Rev Respir Dis 100: 334-341, 1969.
112. Vivona ML, Matthay M, Chabaud MB, Friedlander G, and Clerici C. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by beta-adrenergic agonist treatment. Am J Respir Cell Mol Biol 25: 554-561, 2001.
113. Vock P, Brutsche MH, Nanzer A, and Bartsch P. Variable radiomorphologic data of high altitude pulmonary edema-features from 60 patients. Chest 100: 1306-1311, 1991.
114. Vock P, Fretz C, Franciolli M, and Bärtsch P. High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology 170: 661-666, 1989.
115. Weiss J, Haefeli WE, Gasse C, Hoffmann MM, Weyman J, Gibbs S, Mansmann U, and Bärtsch P. Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High Alt Med Biol 4: 355-366, 2003.
116. West JB, Mathieu-Costello O, Jones JH, Birks EK, Logemann RB, Pascoe JR, and Tyler WS. Stress failure of pulmonary capillaries in racehorses with exercise-induced pulmonary hemorrhage. J Appl Physiol 75: 1097-1109, 1993.
117. West JB, Tsukimoto K, Mathieu-Costello O, and Prediletto R. Stress failure in pulmonary capillaries. J Appl Physiol 70: 1731-1742, 1991.
118. Whayne TF Jr and Severinghaus JW. Experimental hypoxic pulmonary edema in the rat. J Appl Physiol 25: 729-732, 1968.
119. Wilson LB and Levitzky MG. Chemoreflex blunting of hypoxic pulmonary vasoconstriction is vagally mediated. J Appl Physiol 66: 782-791, 1989.
120. Younes M, Bshouty Z, and Ali J. Longitudinal distribution of pulmonary vascular resistance with very high pulmonary flow. J Appl Physiol 62: 344-358, 1987.
121. Young SL, Ho YS, and Silbajoris RA. Surfactant apoprotein in adult rat lung compartments is increased by dexamethasone. Am J Physiol Lung Cell Mol Physiol 260: L161-L167, 1991.
122. Young SL and Silbajoris R. Dexamethasone increases adult rat lung surfactant lipids. J Appl Physiol 60: 1665-1672, 1986.
123. Zhao Y, Packer CS, and Rhoades RA. Pulmonary vein contracts in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 265: L87-L92, 1993.